Stock Analiz

PROCEPT BioRobotics Corp (PRCT) stock forecast and price target

Price $23.80 · data as of November 13, 2026

12-month price target

Average target$22.75
Upside / downside−4.4%
Analysts12
ConsensusHold
Low $16.00Average $22.75High $30.00

Gold marker: average target · white marker: today’s price ($23.80)

Analyst ratings

Strong buy 2Buy 3Hold 9Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.72−0.2%$395M
Next fiscal year
ends December 31, 2027
$-1.24+27.8%$474M
Next quarter
ends December 31, 2026
$-0.23+57.1%$120M
Quarter after
ends March 31, 2027
$-0.43+22.4%$105M

Consensus of the analysts covering PROCEPT BioRobotics, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.

Our model vs. Wall Street

Analysts see 4.4% downside over 12 months. Our discounted cash flow model with moderate assumptions puts PROCEPT BioRobotics’s intrinsic value about 82% below today’s market value, and it scores 1.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the PROCEPT BioRobotics stock price target?

The average 12-month target from 12 analysts is $22.75, 4.4% below the current price of $23.80 Targets range from $16.00 to $30.00.

Is PROCEPT BioRobotics a buy according to analysts?

The consensus rating is “Hold” (2 strong buy, 3 buy, 9 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is PROCEPT BioRobotics expected to earn?

Analysts expect EPS of $-1.72 for the fiscal year ending December 31, 2026 and $-1.24 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.